Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|18|6|662-664
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.6, 2018-11, pp. : 662-664
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Guidelines for bullous pemphigoid management
Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. :
Access to resources
Recommend
Penicillamine: Bullous pemphigoid: case report
Reactions Weekly, Vol. 1, Iss. 1240, 2009-01 ,pp. :
Rifampicin: Bullous pemphigoid: case report
Reactions Weekly, Vol. 1, Iss. 1367, 2011-01 ,pp. :
Bullous Pemphigoid: From Bench to Bedside
Drugs, Vol. 65, Iss. 7, 2005-01 ,pp. :
Tibolone: First report of bullous pemphigoid: case report
Reactions Weekly, Vol. 1, Iss. 1246, 2009-01 ,pp. :